Skip to content

Efficacy of Gauradya ghrut in Nadivrana

A RANDOMISED CONTROL CLINICAL TRIAL OF GAURADYA GHRUTA IN NADI VRANA WITH SPECIAL REFFERENCE TO SINUS

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/03/041224
Enrollment
64
Registered
2022-03-21
Start date
Unknown
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L059- Pilonidal cyst and sinus without abscess

Interventions

None listed

Sponsors

Hon Annasaheb Dange Ayurveda Medical College and Post Graduation Research Training Center Ashta
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patient presenting with classical signs and symptoms of nadivrana with external opening on body surface. 2) Patient age group between 15-60 years. 3) Both genders. 4) Patient ready to take treatment. 5) Patient who are reluctant for surgery.

Exclusion criteria

Exclusion criteria: 1) Patient reluctant to take treatment. 2) Age group below 15years and above 60years. 3) Congenital sinus. 4) Nadivrana with systemic diseases like diabetes mellitus, tuberculosis, actinomycosis, bleeding disorders, AIDS. 5) Osteomylitis followed by sinus. 6) Patient having complicated sinuses, patient having neoplastic sinus. 7) If sinus tract is more then 5cm.

Design outcomes

Primary

MeasureTime frame
To determine the efficacy of Gauradya ghruta in management of nadivrana with special reference to sinusTimepoint: 4 weeks

Secondary

MeasureTime frame
To review literature on Nadi VranaTimepoint: 4 weeks

Countries

India

Contacts

Public ContactDr Prashant Date

Hon. Shri Annasaheb Dange Ayurveda Medical college and Post Graduation Research Center, Ashta

drdateprashant@gmail.com9822706975

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026